CommentaryHarm reduction healthcare: From an alternative to the mainstream platform?
References (19)
- et al.
The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings
International Journal of Drug Policy
(2008) - et al.
Injecting drug users: A stigmatised and stigmatising population
International Journal of Drug Policy
(2009) Case study: Accessible primary health care—A foundation to improve health outcomes for people who inject drugs
International Journal of Drug Policy
(2007)- et al.
GP attitudes to managing drug- and alcohol-dependent patients: A reluctant role
Drug and Alcohol Review
(2000) - et al.
Trust and free will as the keys to success for the low threshold health service centers (LTHSC)
(2008) - et al.
Hepatitis C-related discrimination among heroin users in Sydney: Drug user or hepatitis C discrimination?
Drug and Alcohol Review
(2003) - et al.
Doing harm reduction better: Syringe exchange in the United States
Addiction
(2009) - et al.
Do mechanisms that link addiction treatment patients to primary care influence subsequent utilization of emergency and hospital care?
Medical Care
(2006) - et al.
From margin to mainstream: The evolution of harm reduction responses to problem drug use in Europe
Drugs: Education, Prevention and Policy
(2008)
Cited by (20)
Alcohol treatment systems in Muslim majority countries: Case study of alcohol treatment policy in Iran
2020, International Journal of Drug PolicyCitation Excerpt :The very different context in many MMCs may act as barriers to implementing some of these approaches, such as integration of BI into PHC in Iran. It is likely that relevant lessons can be learnt from the experience of attempts to implement screening, BI and treatment for illicit drugs in PHC of western countries (Islam, Day & Conigrave, 2010; Islam, Topp, Conigrave, & Day, 2013). The highly stigmatised status of alcohol makes it difficult to implement several aspects of global alcohol policy.
Primary healthcare outlets that target injecting drug users: Opportunity to make services accessible and acceptable to the target group
2012, International Journal of Drug PolicyThe accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: A narrative synthesis of literature
2012, International Journal of Drug PolicyCitation Excerpt :Harm reduction is still woefully under-funded (Bergenstrom et al., 2010). It might, therefore, be reasonable to consider the gradual mainstreaming of these services into traditional healthcare delivery (Islam, Day, & Conigrave, 2010). However, achieving mainstreaming is challenging and it is unlikely that there will be a single best answer for all settings due to substantial geographical, cultural, policy and practice variation.
Access to harm reduction services in Atlantic Canada: Implications for non-urban residents who inject drugs
2012, Health and PlaceCitation Excerpt :Given the minimal resources of harm reduction organizations, and the remote location of many non-urban communities, one potential solution – that is perhaps more realistic and economically viable – is to integrate harm reduction approaches into existing health and social services. Indeed, harm reduction advocates have identified that it is unlikely that harm reduction can be sufficiently scaled-up to meet current and future needs by replicating existing community-based micro-projects such as NEPs (Islam et al., 2010). Rather, to maximize the positive effects of such initiatives, harm reduction must transition “from the exceptional to the mainstream” (Stimson and O’Hare, 2010, p. 92).
A primary healthcare clinic in a needle syringe program may contribute to HIV prevention by early detection of incident HIV in an injecting drug user
2011, Australian and New Zealand Journal of Public Health